A preparation method of enzalutamide and its intermediates

Intermediate compound 4 was prepared by reaction of 2-aminoisobutyric acid with carbon disulfide, and with N-methyl-4-bromo-2-fluoro-benzamide in the presence of a nickel catalyst and an inorganic base, the solution was solved In the prior art, the raw materials are expensive, operating hazards and environmental pressures in the enzalubic preparation method, and efficient and safe industrial production is achieved.

CN118702632BActive Publication Date: 2024-11-19AURISCO PHARMACEUTICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411180291.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-27
Publication Date
2024-11-19
Estimated Expiration
2044-08-27

AI Technical Summary

Technical Problem

The existing preparation methods for enzalubamine have problems such as using expensive and difficult-to-preserve raw materials, lively and flammable and explosive chemicals, highly toxic substances, and complex operation and high environmental pressure, which leads to inappropriate large-scale industrial production.

Method used

High-purity intermediate compound 4 is prepared by reacting 2-aminoisobutyric acid with carbon disulfide, and reacted with N-methyl-4-bromo-2-fluoro-benzamide in the presence of a nickel catalyst and an inorganic base to form Enzalu amine, adopts mild reaction conditions and simple process flow.

Benefits of technology

The production of enzalubic acid with high yield and high purity is achieved, reducing raw material costs and process complexity, and improving operational safety and suitability for large-scale industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118702632B_ABST
    Figure CN118702632B_ABST
Patent Text Reader

Abstract

The present invention provides a method for preparing enzalutamide and its intermediate compound 4. The method for preparing compound 4 comprises taking cheap and readily available 2-aminoisobutyric acid as a starting material, reacting it with carbon disulfide to obtain compound 2, and then reacting compound 2 with 4-amino-2-trifluoromethylbenzonitrile to obtain intermediate compound 4. Intermediate compound 4 reacts with N-methyl-4-bromo-2-fluoro-benzamide to obtain enzalutamide. The reaction formula is shown below. The raw materials used in the preparation method of the present invention are cheap and readily available, the process is simple and reliable, the post-processing efficiency is high, the yield is high, and it is very suitable for industrial large-scale production. #imgabs0#.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of organic compound synthesis, and more specifically, relates to a preparation method of enzalutamide and an intermediate thereof. Background Art

[0002] Enzalutamide is an androgen receptor signaling inhibitor that has been approved in China for the treatment of adult patients with non-metastatic castration-resistant prostate cancer (nmCRPC) at high risk of metastasis, and adult patients with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or have mild symptoms after failure of androgen deprivation therapy (ADT) and have not received chemotherapy. Its structural formula is as follows:

[0003] .

[0004] Regarding the preparation method of enzalutamide or its intermediates, the routes reported in the prior art are as follows:

[0005] Prior art CN112645880A reports a route 1 for preparing enzalutamide:

[0006] .

[0007] The preparation method of route 1 comprises: ammonium thiocyanate first reacts with benzoyl chloride to generate benzoyl isothiocyanate, benzoyl isothiocyanate then reacts with 4-amino-2-trifluoromethylbenzonitrile, benzoyl group is removed under alkaline conditions to obtain compound A, compound A reacts with methyl 2-methyl-2-chloropropionate to synthesize key intermediate compound B, compound B reacts with 4-bromo-2-fluoro- in the presence of inorganic base and cuprous iodide N- Enzalutamide is obtained by the reaction of methylbenzamide (the yield of this step is 88.7%, and the purity is 98.2%). The benzoyl chloride used in this route is not only expensive but also difficult to store, and the benzoyl group is subsequently removed as a protecting group, resulting in low atom economy of the entire route and high industrial production costs.

[0008] Prior art CN104844520A reports route 2 for preparing enzalutamide:

[0009] .

[0010] The preparation method of route 2 includes: thiourea reacts with methyl 2-methyl-2-chloro-propionate to generate compound 3, compound 3 reacts with 2-trifluoromethyl-4-bromo-benzonitrile in the presence of sodium hydride to generate key intermediate compound 5 (the yield of this step is 65.1%), and compound 5 reacts with compound 6 in a system containing DMF and sodium hydride to generate enzalutamide (the yield of this step is 87.3%). This method uses sodium hydride in two steps. The substance is too active and is a flammable, explosive and difficult to store chemical substance. It brings great challenges to actual safe production operations and is not suitable for industrial large-scale production.

[0011] Prior art CN116199633A reports a route 3 for preparing a key intermediate of enzalutamide, compound B:

[0012] .

[0013] The preparation method of route 3 comprises: reacting 4-amino-2-trifluoromethylbenzonitrile with thiophosgene, and then reacting the obtained intermediate with methyl aminoisobutyrate hydrochloride to synthesize compound B. The thiophosgene used in this method is a highly toxic substance, and the intermediate obtained by this route has low purity, and column chromatography is required to purify the product, which is complicated to operate, has great environmental pressure, and has limited production capacity, which is not conducive to industrial production.

[0014] Therefore, from the perspective of product commercialization, it is necessary to develop a more efficient method for synthesizing enzalutamide, which can not only ensure the product yield and product quality, but also take into account the operational safety of workshop personnel and is suitable for industrial large-scale production. Summary of the invention

[0015] In view of the defects of the preparation method of enzalutamide in the prior art, the present invention provides a preparation method of an enzalutamide intermediate, compound 4, in which the raw materials used are cheap and easily available, the process is simple and reliable, the treatment is simple and the yield is high, and the method is suitable for industrial large-scale production.

[0016] To achieve the above object, the present invention adopts the following scheme:

[0017] A method for preparing compound 4, comprising the following steps:

[0018] Compound 2 reacts with compound 3 to generate compound 4. The reaction formula is as follows:

[0019] .

[0020] In another preferred embodiment, the reaction temperature of compound 2 and compound 3 is 30°C to 55°C, more preferably 40°C to 45°C.

[0021] In another preferred embodiment, the molar ratio of compound 2 to compound 3 is 1:1-3, more preferably 1:1.1-1.5, and most preferably 1.2.

[0022] In another preferred embodiment, the solvent used in the reaction is selected from ethanol, methanol, isopropanol, sec-butanol, tert-butanol, acetonitrile, tetrahydrofuran, isopropyl acetate, ethyl acetate or a combination thereof, or a combination thereof. In another more preferred embodiment, the solvent used in the reaction is selected from methanol or ethanol.

[0023] In another preferred embodiment, the weight volume ratio of compound 2 to the solvent is 1 g / 5 mL to 20 mL, more preferably 1 g / 8 mL to 15 mL, for example, 1 g / 12 mL.

[0024] In another preferred embodiment, in the preparation method of compound 4, the method of compound 2 is prepared by the following steps:

[0025] In the presence of a base, compound 1 reacts with carbon disulfide to generate compound 1. The reaction formula is as follows:

[0026] .

[0027] In another preferred embodiment, the base is selected from an organic base or an inorganic base. In another preferred embodiment, the organic base is selected from diisopropylamine, N,N-diisopropylethylamine, triethylamine, N-methylpiperazine, N,N,N',N'-tetramethylethylenediamine, pentamethyldiethylenetriamine, N-methylmorpholine, 1,8-diazabicyclo[5.4.0]undec-7-ene, pyridine, or a combination thereof. In another preferred embodiment, the inorganic base is selected from sodium hydroxide, potassium hydroxide, lithium hydroxide, barium hydroxide, potassium carbonate, sodium carbonate, lithium carbonate, potassium phosphate, or a combination thereof.

[0028] In another more preferred embodiment, the base used for the reaction of compound 1 with carbon disulfide is selected from an organic base. In another more preferred embodiment, the organic base is selected from triethylamine or diisopropylamine.

[0029] In another preferred embodiment, the temperature for the reaction of compound 1 with carbon disulfide is 30°C to 55°C, more preferably 40°C to 45°C.

[0030] In another preferred embodiment, the molar ratio of compound 1: carbon disulfide: base is 1:1-3:1-8, more preferably 1:1-2:2-4, and most preferably 1:1.2:3.0.

[0031] In another preferred embodiment, the solvent used for the reaction of compound 1 with carbon disulfide is selected from ethanol, methanol, acetonitrile, tetrahydrofuran, acetone, N,N-dimethylformamide, N,N-dimethylacetamide, chloroform, dichloromethane, isopropyl acetate, ethyl acetate or a combination thereof. In another more preferred embodiment, the solvent used is selected from tetrahydrofuran.

[0032] In another preferred embodiment, the weight volume ratio of compound 1 to the solvent is 1 g / 2 mL to 20 mL, more preferably, 1 g / 3 mL to 15 mL, for example 1 g / 5 mL.

[0033] In another preferred embodiment, the preparation method of compound 4 provided by the present invention comprises the following steps:

[0034] (1) In the presence of a base, compound 1 reacts with carbon disulfide to generate compound 1,

[0035] (2) Compound 2 reacts with compound 3 to generate compound 4. The reaction formula is as follows:

[0036] .

[0037] In step (1), the base is selected from triethylamine or diisopropylamine, and the solvent is selected from tetrahydrofuran.

[0038] In step (2), the solvent used is selected from methanol or ethanol.

[0039] Another aspect of the present invention provides a method for preparing enzalutamide, which comprises the following steps:

[0040] (a) providing compound 4, wherein compound 4 is obtained according to the preparation method of compound 4,

[0041] (b) Compound 4 reacts with compound 5 to generate compound 6, and the reaction formula is as follows:

[0042] .

[0043] In another preferred embodiment, a nickel catalyst and an inorganic base are also present in the reaction system of step (b). In another preferred embodiment, the metal catalyst is selected from nickel acetate, nickel chloride, nickel bromide, nickel iodide or a combination thereof, more preferably, nickel chloride. In another preferred embodiment, the inorganic base catalyst is selected from potassium phosphate, potassium carbonate, lithium hydroxide, sodium hydroxide, potassium hydroxide, barium hydroxide, sodium carbonate, lithium carbonate or a combination thereof, more preferably, potassium phosphate.

[0044] In another preferred embodiment, in step (b), the reaction temperature is 80°C to 150°C, more preferably, 100°C to 110°C.

[0045] In another preferred embodiment, in step (b), the molar ratio of compound 4 to compound 5 is 1:1-3, more preferably, 1:1.0-1.5, and most preferably 1:1.1-1.2.

[0046] In another preferred embodiment, in step (b), the molar ratio of compound 4 to the catalyst and the inorganic base is 1: 0.05~0.5:1~5, more preferably, 1: 0.1~0.3: 1.5~3.0, and most preferably 1: 0.2:2.0.

[0047] In another preferred embodiment, in step (b), the solvent used is selected from tetrahydrofuran, N,N-dimethylformamide, N,N-dimethylacetamide, dioxane, N-methylpyrrolidone, or a combination thereof. In another preferred embodiment, in step (b), the solvent used is selected from N,N-dimethylformamide.

[0048] In another preferred embodiment, the weight volume ratio of the compound 4 to the solvent is 1 g / 2 mL to 15 mL, more preferably, 1 g / 3 mL to 8 mL, for example, preferably 1 g / 5 mL.

[0049] In another preferred embodiment, the preparation method of enzalutamide provided by the present invention comprises the following steps:

[0050] (a-1) In the presence of a base, compound 1 reacts with carbon disulfide to generate compound 1,

[0051] (a-2) Compound 2 reacts with compound 3 to generate compound 4.

[0052] (b) Compound 4 reacts with compound 5 to generate enzalutamide, and the reaction formula is as follows:

[0053] .

[0054] In step (a-1), the base is selected from triethylamine or diisopropylamine, and the solvent is selected from tetrahydrofuran.

[0055] In step (a-2), the solvent used is selected from methanol, ethanol or isopropanol.

[0056] In step (b), a nickel catalyst and an inorganic base are also present in the reaction system, the nickel catalyst is selected from nickel chloride, and the inorganic base catalyst is selected from potassium phosphate.

[0057] In another preferred embodiment, the preparation method of enzalutamide provided by the present invention comprises the following steps: in the presence of a nickel catalyst and an inorganic base, compound 4 reacts with compound 5 to generate enzalutamide, and the reaction formula is as follows:

[0058] .

[0059] The nickel catalyst is selected from nickel acetate, nickel chloride, nickel bromide, nickel iodide or a combination thereof, and the inorganic base is selected from potassium phosphate, potassium carbonate, lithium hydroxide, sodium hydroxide, potassium hydroxide, barium hydroxide, sodium carbonate, lithium carbonate or a combination thereof. BRIEF DESCRIPTION OF THE DRAWINGS

[0060] Figure 1 This is the HPLC detection spectrum of compound 4 prepared in Example 2-1.

[0061] Figure 2 This is the HPLC detection spectrum of enzalutamide prepared in Example 3-1.

[0062] Figure 3 This is the HPLC detection spectrum of compound 4 prepared in Comparative Example 4-1.

[0063] Figure 4 This is the HPLC detection spectrum of Enzalutamide prepared in Comparative Example 4-2. DETAILED DESCRIPTION

[0064] In view of the defects existing in the preparation method of enzalutamide in the prior art, the inventors of the present application have conducted in-depth research and found that a high-purity key intermediate compound 4 can be prepared in high yield by using 2-aminoisobutyric acid as a raw material and reacting it with carbon disulfide and 4-amino-2-trifluoromethylbenzonitrile in sequence. The compound 4 can be further reacted with N-methyl-4-bromo-2-fluoro-benzamide to obtain the target compound enzalutamide.

[0065] Preparation of compound 4

[0066] In some specific embodiments of the present invention, the preparation method of compound 4 comprises the following steps:

[0067] (1) In the presence of a base, compound 1 reacts with carbon disulfide to generate compound 1,

[0068] (2) Compound 2 reacts with compound 3 to generate compound 4. The reaction formula is as follows:

[0069] .

[0070] In step (1), the base may be an organic base or an inorganic base. Available organic bases include but are not limited to diisopropylamine, N,N-diisopropylethylamine, triethylamine, N-methylpiperazine, N,N,N',N'-tetramethylethylenediamine, pentamethyldiethylenetriamine, N-methylmorpholine, 1,8-diazabicyclo[5.4.0]undec-7-ene and pyridine. Inorganic bases that can be used in the present invention include but are not limited to sodium hydroxide, potassium hydroxide, lithium hydroxide, barium hydroxide, potassium carbonate, sodium carbonate, lithium carbonate and potassium phosphate. In step (1), available solvents include but are not limited to ethanol, methanol, acetonitrile, tetrahydrofuran, acetone, N,N-dimethylformamide, N,N-dimethylacetamide, chloroform, dichloromethane, isopropyl acetate, ethyl acetate or a combination thereof. Considering that the solvents used are all organic solvents, the present invention preferably uses an organic base. The amounts of the base and the solvent are all conventional amounts in the art.

[0071] The reaction temperature in step (1) is 30°C to 55°C.

[0072] In some specific embodiments of the present invention, the solvent used in step (1) is tetrahydrofuran, and the base used is triethylamine. After the reaction is completed, the reaction solution is cooled to 0°C-10°C and filtered to obtain a high-purity compound 2, which can be directly used in the next reaction.

[0073] In step (2), the solvents that can be used include but are not limited to ethanol, methanol, isopropanol, sec-butanol, tert-butanol, acetonitrile, tetrahydrofuran, isopropyl acetate, ethyl acetate or a combination thereof. The amount of the solvent used is the conventional amount in the art.

[0074] The reaction temperature in step (2) is 30°C to 55°C.

[0075] In some specific embodiments of the present invention, the solvent used in step (2) is methanol or ethanol. After the reaction is completed, the reaction solution is concentrated under reduced pressure to 1 / 2 to 1 / 4 of the original volume, and the temperature is reduced to 0°C to 10°C. High-purity compound 4 can be obtained by filtration and can be directly used in the next reaction.

[0076] Preparation of Enzalutamide

[0077] In some specific embodiments of the present invention, the method for preparing enzalutamide comprises the following steps:

[0078] Compound 4 reacts with compound 5 to generate enzalutamide, and the reaction formula is as follows:

[0079] .

[0080] This step can be carried out according to the method reported in the prior art, such as CN112645880A, or according to the preparation method of the present invention. The step provided by the present invention is: in the presence of a nickel catalyst and an inorganic base, compound 4 reacts with compound 5 to produce enzalutamide. Available nickel catalysts include but are not limited to nickel acetate, nickel chloride, nickel bromide and nickel iodide. Available inorganic bases include but are not limited to potassium phosphate, potassium carbonate, lithium hydroxide, sodium hydroxide, potassium hydroxide, barium hydroxide, sodium carbonate and lithium carbonate. Available solvents include but are not limited to tetrahydrofuran, N,N-dimethylformamide, N,N-dimethylacetamide, dioxane and N-methylpyrrolidone.

[0081] The reaction temperature of this step is 80°C to 150°C.

[0082] In some specific embodiments of the present invention, the solvent used is N,N-dimethylformamide, the catalyst is nickel chloride, and the inorganic base is potassium phosphate. After the reaction is completed, water is directly added to the reaction solution, which is filtered. The filter cake obtained is recrystallized using isopropanol to obtain a high-purity target product.

[0083] In the description of the present invention, "purity" refers to the purity determined by HPLC.

[0084] Compared with the prior art, the preparation method of enzalutamide and its intermediate (Compound 4) of the present invention has the following advantages:

[0085] 1. The starting materials used, 2-aminoisobutyric acid and carbon disulfide, are cheap and readily available.

[0086] 2. The two-step reaction conditions for preparing intermediate compound 4 are relatively mild and are carried out at 30°C~55°C. The post-treatment process of the reaction solution is relatively simple, and the reaction solution can be directly cooled or concentrated and then cooled. The yield and purity of the obtained product are both high. The yield of the first step reaction can reach 90%, and the product purity can reach 99.6%. The molar yield of the second step reaction can reach 97%, and the product purity can reach 99.7%.

[0087] 3. The method for preparing enzalutamide from the intermediate compound 4 has low catalyst cost and simple post-treatment. Water is added to the reaction solution and filtered to obtain a crude product. The crude product can be recrystallized to obtain high-purity enzalutamide in high yield. The molar yield can reach 91% and the product purity can reach 99.7%.

[0088] The present invention is further described in detail below in conjunction with specific embodiments, and the protection content of the present invention is not limited to the following embodiments. The processes, conditions, reagents, experimental methods, etc. in the following embodiments, except for the contents specifically mentioned below, are all common knowledge and common common sense in the art, and the present invention has no special restrictions. If not specifically specified, the raw materials used in the present invention are all commercially available or can be prepared according to the prior art.

[0089] The HPLC analysis and testing instrument used in the following examples is Agilent 1260, the chromatographic column is Supelco Ascentis Express 90A C8 150 mm×4.6 mm, 2.7 um, the detector is a UV detector with a wavelength of 210-285 nm, the mobile phase A is potassium dihydrogen phosphate aqueous solution, and the mobile phase B is acetonitrile.

[0090] The nuclear magnetic resonance spectrometer was Bruker AVANCE NEO 500.

[0091] The liquid chromatography-mass spectrometer was Shimadzu LCMS-2020.

[0092] Example 1-1: Synthesis of Compound 2

[0093] .

[0094] At room temperature, 10.00 g (96.97 mmol) of 2-aminoisobutyric acid and 9.81 g (1.0 eq) of triethylamine were added to 100 ml of ethanol, and then 7.38 g (1 eq) of carbon disulfide was added. The temperature was raised to 40°C~45°C and kept for 15 hours. After the reaction, the temperature was lowered to 0°C~10°C and filtered to obtain 13.52 g of compound 1 with a yield of 85.5% and a purity of 98.87%. ESI-MS (m / z): 162 [M+H] + .

[0095] Examples 1-2 to 1-7: Synthesis of Compound 2

[0096] The raw materials of these examples are the same as those of Example 1-1, with 10.00 g of 2-aminoisobutyric acid as the substrate. The differences are that the amount of carbon disulfide, the type and amount of the base, and the type and amount of the reaction solvent are adjusted. The specific experimental conditions and experimental results of these examples are shown in Table 1 below.

[0097] .

[0098] It can be seen from Table 1 that in the process of preparing compound 1, triethylamine is the best organic base, tetrahydrofuran is the best solvent, and the best equivalent of carbon disulfide is 1.2 eq.

[0099] Although inorganic bases can also be used in the reaction based on the reaction principle, considering that the solvents used in the reaction are all organic solvents and inorganic bases have poor solubility or are insoluble, only organic bases are used in the above Examples 1-1 to 1-7.

[0100] Example 2-1: Synthesis of Compound 4

[0101] .

[0102] At room temperature, 10.00 g (61.77 mmol, purity of about 99.6%) of compound 2 and 13.80 g (74.12 mmol, 1.2 eq) of 4-amino-2-trifluoromethylbenzonitrile (compound 3) were added to 120 ml of methanol, and the temperature was raised to 40°C~45°C. The reaction was kept warm for 8 hours. According to thin layer chromatography, the target compound was obtained and the raw materials were basically reacted. The reaction was stopped, and a part of the solvent was concentrated under reduced pressure (for example, 50 ml~60 ml of the solvent was concentrated under reduced pressure), and then the temperature was reduced to 0°C~10°C, and filtered to obtain 18.82 g of compound 4, with a yield of 96.9% and a purity of 99.68% (see Figure 1 ).

[0103] ESI-MS (m / z): 314 [M+H] + .

[0104] Examples 2-2 to 2-5: Synthesis of Compound 2

[0105] These Examples 2-2 to 2-5 are the same as Example 2-1, all using 10.00 g of Compound 2 as the substrate. The difference is that the amount of Compound 3 and the type and amount of the reaction solvent are adjusted. The specific experimental conditions and experimental results of these Examples are shown in Table 2.

[0106] .

[0107] It can be seen from Table 2 that in the process of preparing compound 2, the optimal equivalent of 4-amino-2-trifluoromethylbenzonitrile is 1.2 eq, and methanol is the best solvent.

[0108] Example 3-1: Synthesis of Enzalutamide

[0109] .

[0110] At room temperature, under nitrogen protection, 10.00 g (31.82 mmol, purity 99.68%) of compound 4, 8.12 g (35.00 mmol, 1.1 eq) of N-methyl-4-bromo-2-fluoro-benzamide, 0.82 g (0.2 eq) of nickel chloride and 13.51 g (2.0 eq) of potassium phosphate were added to 50 ml of N,N-dimethylformamide, the temperature was raised to 100°C~110°C, the reaction was carried out after 20 hours of heat preservation, 500 ml of water was added, stirred for 1 hour, cooled to 5°C~10°C, filtered, and the filter cake was recrystallized with 60 g of isopropanol. After drying, 13.52 g of enzalutamide was obtained, with a yield of 91.3% and a purity of 99.76% (see Figure 2 ).

[0111] ESI-MS (m / z): 465 [M+H] + .

[0112] 1 H-NMR (500MHz, DMSO- d 6) δ 1.53(s, 6H), 2.79(d, 3H), 7.41-7.31(m, 1H),7.43-7.42(d, 1H), 7.76(s, 1H), 8.06(s, 1H), 8.28-8.27(d, 1H), 8.39-8.38(d,1H), 8.42-8.41(d,1H).

[0113] Examples 3-2 to 3-6: Synthesis of Enzalutamide

[0114] These Examples 3-2 to 3-6 are the same as Example 3-1, all using 10.00 g of Compound 2 as the substrate, except that the amount of N-methyl-4-bromo-2-fluoro-benzamide, the type of reaction solvent, the type of nickel catalyst, the type and amount of inorganic base, etc. were adjusted. The specific experimental conditions and experimental results of these Examples are shown in Table 3 below.

[0115] .

[0116] It can be seen from Table 3 that in the process of preparing enzalutamide, the optimal equivalent of N-methyl-4-bromo-2-fluoro-benzamide is 1.1 eq, N,N-dimethylformamide is the best solvent, the optimal equivalent of nickel chloride is 0.2 eq, and the optimal equivalent of potassium phosphate is 2.0 eq.

[0117] Comparative Example 4-1: Synthesis of Compound 4

[0118] Steps (1) and (2) of Example 1 of the prior art CN116199633A were repeated to prepare compound 4 using 4-amino-2-trifluoromethylbenzonitrile and thiophosgene aqueous solution as raw materials. It was found that the purity of the final crude compound 4 was only about 85%, and the purity after column chromatography purification was only 98.56% (see Figure 3 ), the yield was 77.8%, and the eluent used for column chromatography purification was a mixture of ethyl acetate and n-heptane in a volume ratio of 7:2.

[0119] Comparative Example 4-2: Synthesis of Compound 4 and Enzalutamide

[0120] Repeating Example 2 of the prior art CN104844520 A, the yield of compound 4 after column chromatography purification was 64.8% and the purity was 95.27%. The eluent used for column chromatography purification was a mixture of ethyl acetate / n-heptane in a volume ratio of 7:2.

[0121] Repeating Example 3 of the prior art, the yield of enzalutamide after column chromatography purification was 87.0% and the purity was 99.65% (see Figure 4 ). The eluent used for column chromatography purification was a mixture of ethyl acetate and n-heptane in a volume ratio of 8:3.

[0122] From the comparison of Comparative Examples 4-1 and 4-2 with Examples 2-1 to 2-6 and 3-1 to 3-7, it can be seen that the yield and purity of the technology of the present invention are higher than those of the prior art when preparing Compound 2 or Enzalutamide.

[0123] All documents mentioned in the present invention are cited as references in this application, just as each document is cited as reference individually. In addition, it should be understood that after reading the above teachings of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the claims attached to this application.

Claims

1. A method for preparing compound 4, characterized in that: The preparation method comprises the following steps: Compound 2 reacts with compound 3 to generate compound 4, and the reaction formula is as follows: 。 2. The preparation method according to claim 1, characterized in that: The temperature for the reaction of compound 2 and compound 3 is 30°C~55°C.

3. The preparation method according to claim 1, characterized in that: The preparation method of the compound 2 comprises the following steps: In the presence of a base, compound 1 reacts with carbon disulfide to generate compound 2. The reaction formula is as follows: 。 4. The preparation method according to claim 3, characterized in that: The base is selected from an organic base or an inorganic base, The organic base is selected from diisopropylamine, N,N-diisopropylethylamine, triethylamine, N-methylpiperazine, N,N,N',N'-tetramethylethylenediamine, pentamethyldiethylenetriamine, N-methylmorpholine, 1,8-diazabicyclo[5.4.0]undec-7-ene, pyridine, or a combination thereof, The inorganic base is selected from sodium hydroxide, potassium hydroxide, lithium hydroxide, barium hydroxide, potassium carbonate, sodium carbonate, lithium carbonate, potassium phosphate or a combination thereof.

5. The preparation method according to claim 4, characterized in that: The base is selected from an organic base, and the organic base is selected from triethylamine or diisopropylamine.

6. A method for preparing compound 4, characterized in that: The preparation method comprises the following steps: (1) In the presence of a base, compound 1 reacts with carbon disulfide to produce compound 2. (2) Compound 2 reacts with compound 3 to generate compound 4. The reaction formula is as follows: , In step (1), the base is selected from triethylamine or diisopropylamine, and the solvent is selected from tetrahydrofuran. In step (2), the solvent used is selected from methanol or ethanol.

7. A method for preparing enzalutamide, characterized in that: The preparation method comprises the following steps: (a) providing compound 4, wherein compound 4 is obtained according to the preparation method according to any one of claims 1 or 6, (b) Compound 4 reacts with compound 5 to generate enzalutamide, and the reaction formula is as follows: 。 8. The preparation method according to claim 6, characterized in that In the reaction system of step (b), a nickel catalyst and an inorganic base are also present. The nickel catalyst is selected from nickel acetate, nickel chloride, nickel bromide, nickel iodide or a combination thereof, and The inorganic base catalyst is selected from potassium phosphate, potassium carbonate, lithium hydroxide, sodium hydroxide, potassium hydroxide, barium hydroxide, sodium carbonate, lithium carbonate or a combination thereof.

9. A method for preparing enzalutamide, characterized in that: The preparation method comprises the following steps: (a-1) In the presence of a base, compound 1 reacts with carbon disulfide to generate compound 2. (a-2) Compound 2 reacts with compound 3 to generate compound 4. (b) Compound 4 reacts with compound 5 to generate compound 6. The reaction formula is as follows: , In step (a-1), the base is selected from triethylamine or diisopropylamine, and the solvent is selected from tetrahydrofuran. In step (a-2), the solvent used is selected from methanol, ethanol or isopropanol, In step (b), a nickel catalyst and an inorganic base are also present in the reaction system. The nickel catalyst is selected from nickel chloride, and The inorganic base catalyst is selected from potassium phosphate.

10. A method for preparing enzalutamide, characterized in that: The preparation method comprises the following steps: In the presence of a nickel catalyst and an inorganic base, compound 4 reacts with compound 5 to generate enzalutamide. The reaction formula is as follows: , The nickel catalyst is selected from nickel acetate, nickel chloride, nickel bromide, nickel iodide or a combination thereof, and The inorganic base is selected from potassium phosphate, potassium carbonate, lithium hydroxide, sodium hydroxide, potassium hydroxide, barium hydroxide, sodium carbonate, lithium carbonate or a combination thereof.